TB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ) derived from the active actin-binding region of thymosin beta-4 (β-4), a naturally occurring 43-amino acid protein present in virtually all human cells. Originally studied in the context of wound healing and cardiac repair, TB-500 has attracted wide interest in regenerative medicine and sports recovery for its ability to promote cell migration, accelerate tissue repair, reduce inflammation, and stimulate new blood vessel formation (angiogenesis). This guide explains what TB-500 is, how it works, what the evidence shows, and key practical considerations.

Note on naming: TB-500 is the synthetic research peptide fragment; the full-length naturally occurring protein is thymosin beta-4 (Tβ4). The terms are often used interchangeably in community discussions, but they are distinct molecules. TB-4 (a common abbreviation for the full peptide) has been the subject of most formal clinical trials.

Fast Answer / Executive Summary

TB-500 is a synthetic peptide fragment of thymosin beta-4 that promotes tissue repair by binding G-actin, stimulating cell migration, reducing inflammation, and driving angiogenesis throughout the body. Preclinical studies demonstrate healing in muscle, tendon, ligament, cornea, and cardiac tissue; a small human pilot trial reported improved wound closure in chronic skin ulcers.[1] It is not FDA-approved and is classified as a prohibited substance by WADA.

Core Concepts & Key Entities

What is thymosin beta-4?
Thymosin beta-4 is the most abundant member of the beta-thymosin family, constitutively expressed in platelets, macrophages, and most nucleated cells. Under injury, it is rapidly released from platelets and immune cells to protect tissues and initiate repair.[1] The actin-sequestering domain (the LKKTETQ peptide fragment corresponding to TB-500) is responsible for most of its cellular effects.

Mechanisms, in one line each:

  • G-actin binding and cytoskeletal remodeling: TB-500 sequesters G-actin (monomeric actin), controlling the pool of actin available for polymerization and enabling rapid cell movement into wound sites.[1]
  • Cell migration: By modulating actin dynamics, TB-500 promotes migration of endothelial cells, keratinocytes, fibroblasts, and stem cells to sites of tissue damage.[1]
  • Angiogenesis: Recruits endothelial progenitor cells and up-regulates VEGF signaling, driving new capillary growth to support tissue regeneration.[2]
  • Anti-inflammatory effects: Down-regulates NF-κB activity and reduces pro-inflammatory cytokines (IL-6, TNF-α), shifting the immune microenvironment toward resolution and repair.[1]
  • Anti-apoptotic: Protects injured cells from programmed cell death via PI3K/Akt signaling, relevant in cardiac and neuronal tissue recovery models.[1]
  • Reduced fibrosis: Modulates myofibroblast activity to minimize scar tissue formation, resulting in more organized, functional repair tissue.[3]

Systemic distribution: A key advantage of TB-500 is its systemic reach. Unlike growth factors that act locally, TB-500 distributes throughout the body after subcutaneous injection and can exert repair effects in distant tissues simultaneously.[1]

Step-by-Step: How to Work With TB-500

Quick orientation: TB-500 is a research peptide not approved for human therapeutic use. It is prohibited by WADA for competitive athletes. The following is educational only.

Step 1 — Select your vial size

TB-500 is commonly available in 5 mg and 10 mg vials. The 5 mg vial is the most practical for a standard loading protocol using 2.5 mg doses. For reconstitution details, see the TB-500 5 mg Dosage Protocol.

Step 2 — Understand loading vs. maintenance

The community-standard protocol follows a two-phase approach:

  • Loading phase (Weeks 1–6): 2.5 mg twice weekly (total 5 mg/week). This saturates tissue levels and jump-starts the repair cascade.
  • Maintenance phase (Weeks 7+): 2.5 mg once weekly or once every two weeks. Sustains healing support at lower peptide cost.

Step 3 — Reconstitution and storage

Add 1.0 mL bacteriostatic water to a 5 mg vial = 5.0 mg/mL. Refrigerate at 2–8°C after reconstitution; use within 28–30 days. Lyophilized powder should be stored frozen at −20°C until use.

Step 4 — Injection approach

TB-500 is typically administered subcutaneously or intramuscularly. Unlike BPC-157 (which benefits from localized injection near the injury), TB-500 distributes systemically, so injection site is more flexible. Common sites: abdomen, thigh, upper arm.

Step 5 — Stack considerations

  • TB-500 + BPC-157 (Wolverine Stack): One of the most popular research combinations. BPC-157 provides localized healing while TB-500 delivers systemic repair support. See our Wolverine Stack article.
  • TB-500 + GHK-Cu + BPC-157 (GLOW Blend): Adds copper tripeptide signaling for collagen and matrix remodeling.

Comparison & Alternatives

Answer-first: TB-500 is the leading systemic tissue-repair research peptide, complementing BPC-157 (which works more locally) and GHK-Cu (which focuses on matrix remodeling).

Peptide Mechanism Best For Evidence Distribution
TB-500 Actin binding, cell migration, angiogenesis, anti-inflammatory Systemic injury recovery, tendon/muscle repair Preclinical + small human data (Tβ4) Systemic
BPC-157 VEGF signaling, FAK-paxillin, NO pathways Localized tissue repair, gut healing Preclinical (extensive) Local + some systemic
GHK-Cu Copper chaperone, collagen synthesis, MMP/TIMP balance Skin repair, wound care, matrix remodeling Human data (skin / wounds) Local (topical or SC)
GLOW Blend Combines GHK-Cu + TB-500 + BPC-157 mechanisms Comprehensive tissue regeneration Based on component evidence Systemic

FAQs

1) What is TB-500?
TB-500 is a synthetic 7-amino acid peptide fragment (Ac-LKKTETQ) derived from the actin-binding domain of thymosin beta-4, a naturally occurring repair protein. It promotes cell migration, reduces inflammation, drives angiogenesis, and reduces fibrosis across multiple tissue types.[1]

2) Is TB-500 the same as thymosin beta-4?
No—TB-500 is a shorter synthetic fragment, while thymosin beta-4 (Tβ4) is the full 43-amino acid protein. TB-500 corresponds to amino acids 17–23 of Tβ4 and retains the key actin-binding and bioactive properties. Clinical trials have been conducted with the full Tβ4 protein.

3) What tissues can TB-500 help repair?
Preclinical studies show repair potential in skeletal muscle, tendons, ligaments, cardiac muscle, cornea, skin, and neural tissue. A notable clinical study (Tβ4 Phase II) reported improved wound closure in venous stasis ulcers.[3]

4) Can TB-500 be stacked with BPC-157?
Yes—this is the most popular research combination, known as the “Wolverine Stack.” TB-500 provides systemic repair and angiogenesis support while BPC-157 offers localized healing and gut protection. The mechanisms complement rather than overlap. See the Wolverine Stack guide.

5) Is TB-500 prohibited in sport?
Yes. Both TB-500 and thymosin beta-4 are classified as non-approved peptide hormones on the WADA Prohibited List (Category S2) and are prohibited both in-competition and out-of-competition for athletes subject to anti-doping rules.

6) What is the typical TB-500 protocol?
A loading phase of 2.5 mg twice weekly for 4–6 weeks, followed by a maintenance phase of 2.5 mg once weekly or every two weeks. For detailed reconstitution and dosing tables, see the TB-500 5 mg Dosage Protocol.

Evidence Highlights

  • Tβ4 review (Goldstein & Kleinman, 2015): Comprehensive overview of thymosin beta-4’s roles in wound healing, cardiac repair, and neural regeneration. Takeaway: Extensive preclinical basis across multiple tissue types.[1]
  • Angiogenesis (Grant et al., 2016): Tβ4 promotes endothelial progenitor cell recruitment and VEGF upregulation in ischemia models. Takeaway: Mechanistic basis for improved blood flow in injured tissue.[2]
  • Phase II wound trial (Philp et al., 2006): Tβ4 gel applied topically to chronic venous stasis ulcers significantly improved wound closure vs. standard care. Takeaway: Human clinical evidence of tissue repair benefit.[3]
  • Cardiac protection: Tβ4 reduced infarct size and promoted cardiac stem cell recruitment in myocardial infarction animal models, leading to ongoing cardiac repair trials.

Next Steps

If you are researching TB-500 dosing:

If you want TB-500 combined with BPC-157:

Takeaway: TB-500 is one of the most scientifically substantiated research peptides for systemic tissue repair, with mechanistic depth in cell migration, angiogenesis, and anti-fibrotic signaling; it is most commonly used alongside BPC-157 in the Wolverine Stack combination.